03/05/2024  21:48:02 Chg. 0.000 Volume Bid03/05/2024 Demandez à03/05/2024 Capitalisation boursière Dividende Y. Rapport P/E
0.985EUR 0.00% 0
Chiffrre d'affaires: 0.000
-Bid taille: - -Ask la taille: - 6.95 Mio.EUR 0.00% -

Description de l'entreprise

Bio-Gate is a medical technology company that employs unique silver technology to endow materials and products with antimicrobial properties. The focus of the product portfolio is medical technology products. Bio-Gate technology is based on the antimicrobial activity of silver ions. The company employs only pure metallic silver. Bio-Gate uses two different technologies. In the first, silver particles are incorporated into cosmetics, paints, veneers or plastics. The second involves coating final products - such as implants or wound dressings - with a silver-containing functional layer. Both technologies use extremely small particles of silver, to ensure that as many silver ions as possible are released.
 

Conseil d'administration & Conseil de surveillance

PDG
Marc Lloret-Grau
Conseil d'administration
Thomas Konradt
Conseil de surveillance
Karl Richter, Volker Rofalski, Prof. Dr. Dr. Volker Alt
 

Données de l'entreprise

Nom: Bio-Gate AG
Adresse: Neumeyerstraße 28-34,D-90411 Nürnberg
Téléphone: +49-911-4775-23–100
Fax: +49-911-4775-23–101
Courriel: info@bio-gate.de
Internet: www.bio-gate.de/
Industrie: Healthcare
Secteur: Medical Products
Sous-secteur: Advanced Medical Devices
Fin de l'exercice financier: 31/12
Flotte libre: 18.30%
IPO date: 05/04/2006

Relations avec les investisseurs

Nom: Gerd Rückel
Téléphone IR: +49-6172-807-309
IR-Fax: -
E-mail IR: presse@bio-gate.de

Principaux actionnaires

Synthos GmbH
 
46.30%
Freefloat
 
18.30%
Mountain Technology AG
 
15.80%
Eiffel Investment Group
 
8.40%
Richter / RFH Ltd.
 
7.30%
Gründer / Management
 
3.90%